BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31570457)

  • 1. Factors that Influence Chemotherapy Treatment Rate in Patients With Upper Limb Osteosarcoma.
    Restrepo DJ; Huayllani MT; Boczar D; Sisti A; Spaulding AC; Moran SL; Aung T; Bagaria S; Manrique OJ; Forte AJ
    Anticancer Res; 2019 Oct; 39(10):5611-5615. PubMed ID: 31570457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
    Restrepo DJ; Huayllani MT; Boczar D; Sisti A; Spaulding AC; Carter RE; Moran SL; Parker AS; Perdikis G; Forte AJ
    Anticancer Res; 2019 Sep; 39(9):5027-5031. PubMed ID: 31519610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive preoperative chemotherapy for osteosarcoma in the lower extremity.
    Nakano H; Tateishi A; Imamura T; Miki H; Abe S; Cho S; Matsushita T; Goto T
    Anticancer Res; 1998; 18(4B):2859-64. PubMed ID: 9713475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
    Yu W; Tang L; Lin F; Yao Y; Shen Z
    Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
    Bacci G; Longhi A; Fagioli F; Briccoli A; Versari M; Picci P
    Eur J Cancer; 2005 Dec; 41(18):2836-45. PubMed ID: 16298125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery).
    Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
    Prilozi; 2008 Dec; 29(2):309-23. PubMed ID: 19259055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of chemotherapy in treatment of osteosarcoma].
    Perek D; Jurczyk-Procyk S
    Pediatr Pol; 1995 Nov; 70(11):939-47. PubMed ID: 8677160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity.
    Zhang HJ; Yang JJ; Lu JP; Lai CJ; Sheng J; Li YX; Hao Q; Zhang SM; Gupta S
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):672-8. PubMed ID: 19296158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
    Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
    Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy of osteosarcoma: no runs, no hits, two men left on base.
    Holland JF
    J Clin Oncol; 1987 Jan; 5(1):4-6. PubMed ID: 3543237
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
    Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
    Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
    Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
    J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant chemotherapy of osteosarcoma].
    Yamawaki S; Isu K; Ubayama Y; Takeda N; Yagi T; Usui M; Isii S
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):180-8. PubMed ID: 2301948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limb-salvage procedures for osteosarcoma. An alternative to amputation.
    Wong AC; Akahoshi Y; Takeuchi S
    Int Orthop; 1986; 10(4):245-51. PubMed ID: 3468089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
    Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
    Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment of high grade osteosarcoma of the extremity: review.
    Bacci G; Lari S
    J Chemother; 2001 Jun; 13(3):235-43. PubMed ID: 11450880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of localized osteosarcoma of the extremities: the Italian experience. Studies of the National Research Council.
    Picci P; Bacci G; Ruggieri P; Madon G; Paolucci G; Marangolo M; Mercuri M; Biagini R; Fabbri N; Casadei R
    Ann Oncol; 1992 Apr; 3 Suppl 2():S13-7. PubMed ID: 1622856
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.